Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery.
Domperidone 20 mg, droperidol 2.5 mg, metoclopramide 10 mg and placebo (saline) were given i.v. 10 min before the end of anaesthesia, to 200 women undergoing major gynaecological surgery, and the incidence of postoperative nausea and vomiting following a standard anaesthetic technique was assessed. Droperidol was significantly more effective than domperidone, metoclopramide or placebo in reducing emetic sequelae. There were no significant differences between the groups in the incidence of extrapyramidal effects and postoperative sedation. Patients given droperidol required less postoperative analgesia than those given domperidone or metoclopramide. It was concluded that, of the drugs studied, droperidol alone was effective in protecting against nausea and vomiting after major gynaecological surgery.
D000005:Abdomen / Q000601:surgery; D000328:Adult; D000932:Antiemetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004294:Domperidone / Q000627:therapeutic use; D004329:Droperidol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010535:Laparoscopy; D008787:Metoclopramide / Q000627:therapeutic use; D009325:Nausea / Q000517:prevention & control*; D011183:Postoperative Complications / Q000517:prevention & control; D011292:Premedication; D014621:Vagina / Q000601:surgery; D014839:Vomiting / Q000517:prevention & control*
D000932:Antiemetics; D004294:Domperidone; D008787:Metoclopramide; D004329:Droperidol